Coexpression of Vimentin and Cytokeratins in Human Melanoma Cell Lines


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Abstract—Molecular heterogeneity in seven human metastatic melanoma cells lines is revealed using a double immunofluorescent assay by flow cytometry. It is evaluated that quite a small population of cells (up to 10%) expressed only vimentin, the main marker of melanoma. Only epithelial cytokeratins expression is revealed in a significantly greater number of cells (from 25 to 50%). The dominant molecular phenotype (50–80% cells expressed both markers), the coexpression of vimentin and cytokeratins, is identified for the first time. The authors assume that the latter phenotype of melanoma cells may be a molecular marker of the tumor’s aggressiveness and metastatic potential.

Sobre autores

T. Bogush

Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation

Autor responsável pela correspondência
Email: tatbogush@mail.ru
Rússia, Moscow

S. Kaliuzhny

Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation

Email: tatbogush@mail.ru
Rússia, Moscow

A. Basharina

Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation

Email: tatbogush@mail.ru
Rússia, Moscow

E. Bogush

Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation

Email: tatbogush@mail.ru
Rússia, Moscow

V. Kirsanov

Sechenov First Moscow State Medical University

Email: tatbogush@mail.ru
Rússia, Moscow

V. Kosorukov

Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation

Email: tatbogush@mail.ru
Rússia, Moscow

O. Burova

Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation

Email: tatbogush@mail.ru
Rússia, Moscow

M. Davydov

Sechenov First Moscow State Medical University

Email: tatbogush@mail.ru
Rússia, Moscow

M. Baryshnikova

Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation

Email: tatbogush@mail.ru
Rússia, Moscow

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Allerton Press, Inc., 2019